Kukje Pharma Co., Ltd. (KRX:002720)
South Korea · Delayed Price · Currency is KRW 3,435.00
+50.00 (1.48%)
Sep 1, 2026, 3:30 PM KST
Kukje Pharma Market Cap
Kukje Pharma has a market cap or net worth of 68.93 billion as of September 1, 2026. Its market cap has decreased by -27.98% in one year.
Market Cap
68.93B
Enterprise Value
84.60B
Revenue
181.27B
Ranking
n/a
PE Ratio
14.09
Stock Price
3,435.00
ChartMarket Cap Chart
Since July 3, 2006, Kukje Pharma's market cap has increased from 29.64B to 68.93B, an increase of 132.54%. That is a compound annual growth rate of 4.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 68.93B | -21.28% |
| Dec 30, 2025 | 87.56B | -15.02% |
| Dec 30, 2024 | 103.03B | -14.06% |
| Dec 28, 2023 | 119.89B | 12.98% |
| Dec 29, 2022 | 106.12B | -5.98% |
| Dec 30, 2021 | 112.86B | -36.19% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SAMSUNG PHARM. Co., LTD. | 124.62B |
| HANDOK | 123.54B |
| Jeil Pharma Holdings | 114.37B |
| HLB Pharmaceutical | 99.84B |
| CMG Pharmaceutical | 84.43B |
| Enzychem Lifesciences | 76.86B |
| CKD Bio | 76.25B |
| Ildong Holdings | 74.19B |